| "Descrizione" by admin (19538 pt) | 2026-Feb-22 12:54 |
Magnesium hydrogen phosphate: properties, uses, pros, cons, safety
Magnesium hydrogen phosphate (synonyms: dibasic magnesium phosphate, dimagnesium phosphate) is a magnesium salt of phosphoric acid used in foods as the additive E343(ii). In practice, it is mainly used as an acidity regulator and buffer, and also as an anti-caking/technological support in certain matrices. Depending on context and dosage, it may also contribute as a source of magnesium and phosphate.

Definition
From a chemical standpoint, it is the salt MgHPO₄; in food applications it is commonly encountered as the trihydrate (MgHPO₄·3H₂O). Its formulation value comes from typical phosphate behavior: in aqueous systems it can help control pH and buffer capacity, influencing stability and performance in selected recipes.
Production process
Industrially, it is produced by a controlled reaction between a magnesium source (e.g., magnesium oxide/hydroxide or magnesium salts) and phosphoric acid or phosphates, followed by precipitation/crystallization, washing, and drying to specification (food grade). For food use, key controls include purity, heavy metals, fluorides, and consistency of form (anhydrous vs hydrated) and particle size.
Key constituents
In a product meeting specifications, the constituents essentially correspond to the substance itself: magnesium hydrogen phosphate (often as the trihydrate) and, when applicable, water of crystallization. The most relevant practical differences depend on hydration state, fineness, and specification-limited impurities.
Identification data and specifications
| Characteristic | Value | Note |
|---|---|---|
| Name | magnesium hydrogen phosphate | also “dimagnesium phosphate” |
| E number | E343(ii) | magnesium phosphates |
| Molecular formula | MgHPO₄ (anhydrous) / MgHPO₄·3H₂O (trihydrate) | hydrated form is very common |
| Molecular weight | 120.28 g/mol (anhydrous) / 174.33 g/mol (trihydrate) | depends on hydration |
| CAS number | 7757-86-0 (substance) / 7782-75-4 (trihydrate) | frequently used in technical sheets |
| EC number (EINECS) | 231-823-5 | EU identifier |
| Calories | 0 kcal | mineral salt, no energy contribution |
| Typical food function | acidity regulator, buffer, technological support | and sometimes magnesium/phosphate contribution |
Physicochemical properties (indicative)
| Characteristic | Indicative value | Note |
|---|---|---|
| Physical state | crystalline powder | generally white and odorless |
| Water solubility | low (slight) | increases in dilute acids |
| Alcohol solubility | negligible | typical for inorganic phosphates |
| Heat stability | good under normal processing | not a leavening agent |
| Effect on pH | buffering in suitable systems | depends on matrix and other phosphates/acids |
| Interactions | complexation/precipitation with ions | to consider in mineral-rich formulations |
Functional role and mechanism of action
In formulation, the core function is its contribution to phosphate buffering: in the presence of water and process conditions, it can help stabilize pH and manage buffer capacity. In certain applications it can improve technological stability (reducing pH drift during shelf life or processing) and may help limit caking in powders when used as a support in dry blends (performance is strongly matrix- and dose-dependent).
Medicine
Magnesium hydrogen phosphate has shown some potential in the orthopedic field, in applications as an effective biomaterial for bone repair (1) and, in combination with fatty acids (omega-6 and omega-7), it promotes the regression and/or resolution of acne symptoms and provides better results than medications (such as isotretinoin), without significant side effects (2).
Main uses in food
Magnesium hydrogen phosphate is used mainly as:
An acidity regulator and buffer in products where pH stability is important.
A technological support in some dry mixes, with potential effects on flowability and powder handling (case-by-case).
A mineral ingredient that may contribute magnesium and phosphate when the nutritional objective is coherent with the formulation.
Cosmetics- INCI Functions
Anticaking agent. This chemical compound facilitates free flow and prevents aggregation or clumping of substances in a formulation by reducing the tendency of certain particles to stick together.
Pros and cons
Pros
Useful as a buffer and acidity regulator in selected systems.
Generally stable and sensorially neutral at appropriate technological doses.
May provide a mineral contribution (magnesium/phosphate) when relevant.
Cons
Limited solubility: in beverages or clear systems it can promote haze/sediment if not managed.
Possible interactions with other minerals/ions in the formula (risk of precipitation or texture shifts).
If overall dietary phosphate intake is already high, added phosphates should be considered in the total balance.
Safety, regulatory, and practical aspects
Safety profile in the finished product
As E343(ii), it is subject to EU purity specifications (including limits for certain contaminants). From a nutritional perspective, practical attention focuses on the overall phosphorus/phosphate balance in the diet, especially in sensitive populations.
Allergen
It is not a label-declarable food allergen.
Contraindications and practical cautions
In people with renal impairment or conditions requiring dietary control of phosphorus and magnesium, the use of phosphate/magnesium-containing fortified foods or supplements should be handled cautiously. In general, the assessment is more critical when the ingredient is used to increase mineral intake, and less critical when it is present only at low technological doses.
Conclusion
Magnesium hydrogen phosphate (E343(ii)) is primarily a functional ingredient as an acidity regulator/buffer and technological support in certain formulations. Its strengths are stability and usefulness for pH control; its main limitations are solubility and potential interactions in mineral-rich matrices, plus the need to consider total phosphate intake in diets already high in phosphorus.
References__________________________________________________________________________
(1) Gelli R, Ridi F. An Overview of Magnesium-Phosphate-Based Cements as Bone Repair Materials. J Funct Biomater. 2023 Aug 14;14(8):424. doi: 10.3390/jfb14080424.
Abstract. In the search for effective biomaterials for bone repair, magnesium phosphate cements (MPCs) are nowadays gaining importance as bone void fillers thanks to their many attractive features that overcome some of the limitations of the well-investigated calcium-phosphate-based cements. The goal of this review was to highlight the main properties and applications of MPCs in the orthopedic field, focusing on the different types of formulations that have been described in the literature, their main features, and the in vivo and in vitro response towards them. The presented results will be useful to showcase the potential of MPCs in the orthopedic field and will suggest novel strategies to further boost their clinical application.
(2) de Souza Pereira R. Treatment of Resistant Acne Vulgaris in Adolescents Using Dietary Supplementation with Magnesium, Phosphate and Fatty Acids (Omega 6 and 7): Comparison with 13-Cis-Retinoic Acid. J Diet Suppl. 2023;20(5):706-716. doi: 10.1080/19390211.2022.2100550.
Abstract The burden of disease associated with acne vulgaris has continued to increase over time in the world population. This continued growth suggests that there is an unmet dermatologic need for this condition worldwide. Potential sequelae of acne, such as scarring, depigmentation, and marked emotional and psychological problems (e.g., low self-esteem), can lead to significant morbidity. The purpose of this study was to investigate whether dietary supplementation with magnesium, phosphate, omega 6 (linoleic acid calcium salt - C18:2 fatty acid Ca salt), and omega 7 (palmitoleic acid calcium salt - C16:1 fatty acid Ca salt) would help patients with acne vulgaris, and to compare with isotretinoin (13-cis retinoic acid). Magnesium has anti-inflammatory properties. Linoleic and palmitoleic acids have bactericidal activity against Staphylococcus aureus and Cutibacterium acnes (formerly known as Propionibacterium acnes). A single-blind randomized study was conducted in which 257 patients were treated with the above dietary supplementation (group A) and 275 patients with isotretinoin (group B) for 6 months. All patients in group A (100%) reported complete regression of symptoms after 6 months of treatment. On the other hand, 187 subjects (68%) in group B reported complete resolution of symptoms during the same period. The difference between the groups (p < 0.05) was statistically significant. The study was approved by the CEP/CONEP. This natural formulation promotes regression and/or cure of acne vulgaris symptoms and has better results than drugs (such as isotretinoin), without significant side effects.
| Evaluate |